Lockebio
Founded 2019 · 9 employees on LinkedIn · 2 known investors
Find your way into Lockebio
Each arrow is one introduction. Sign up to fill in the first one.
Ask Mobeen Lalani to introduce you to Cathy Tie
You →Mobeen · together at Lockebio →Cathy
Ask Jamie Chen to introduce you to Josh Rosaasen
You →Jamie · together at Lockebio →Josh
Sign up to find every way you can get introduced to Lockebio
- Your email: who you already know at Lockebio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Lockebio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Locke Bio operates a white-labeled digital health platform enabling brands to launch integrated telehealth services with telemedicine consultations, patient intake, pharmacy networks, and payment processing. The platform serves direct-to-consumer brands seeking to distribute prescription drugs and healthcare services with an e-commerce experience.
Founders & leadership
Lockebio was founded in 2019 by Cathy Tie.


Investors · 2
How we know: IKJ Capital's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Lockebio do?
- Locke Bio operates a white-labeled digital health platform enabling brands to launch integrated telehealth services with telemedicine consultations, patient intake, pharmacy networks, and payment processing. The platform serves direct-to-consumer brands seeking to distribute prescription drugs and healthcare services with an e-commerce experience.
- Who founded Lockebio?
- Lockebio was founded by Cathy Tie in 2019.
- Who are Lockebio's investors?
- Lockebio's investors include IKJ Capital, Ten13.


